GlassScriptPhysician profile
Edward James Miller
NPI 1366617458
$35,674.56
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,269 · 2020: $2,000 · 2023: $10K · 2024: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $20K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,004 · Consulting Fee: $3,395 · Travel and Lodging: $1,938 · Food and Beverage: $68.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $20,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,004.00 |
| Consulting Fee | $3,395.00 |
| Travel and Lodging | $1,938.24 |
| Food and Beverage | $68.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $23,938.24 | 2020-2024 | |
| Pfizer International LLC | $5,004.00 | 2023 | |
| Csl Behring | $3,395.00 | 2023 | |
| Bracco Diagnostics INC. | $3,147.73 | 2019 | |
| Akcea Therapeutics, INC. | $121.41 | 2019 | |
| Alnylam Pharmaceuticals INC. | $68.18 | 2023 | Amvuttra |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.